Catalent announced that professor David Schaffer has been appointed to the advisory board of the company's biologics business. Professor Schaffer joins the current board's members, Carolyn Bertozzi, Ph.D., Barry Buckland, Ph.D., Michael Buckley, Ph.D., Daniel R. Marshak, Ph.D., Edward R. Robinson, and Matthew Stober. Professor Schaffer serves as Director of the Berkeley Stem Cell Center, in addition to holding a position as a professor of chemical and biomolecular engineering, bioengineering, and neuroscience at University of California, Berkeley.